Private-equity firm Thoma Bravo taking company public at an estimated market cap of $11 billion in its return to the stock market

“We remain confident in our ability to return to pre-pandemic operating margins in the coming years,” said Pfizer CFO David Denton.

The company says 2025 guidance reflects “weaker” market view on biofuel and trade-policy turmoil.

A higher-dose formulation of Eylea saw U.S. sales more than double

PayPal’s stock is down 6%, with an analyst noting that growth in branded-checkout volume seems to have trailed buy-side expectations.

Traditional insurance models aren’t able to handle escalating natural disaster risks.

The streaming service reported a double-digit rise in monthly active users.

Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset better-than-expected fourth-quarter earnings.

AI-fueled productivity growth, combined with realistic and constructive immigration reform, would put the U.S. economy on more solid footing.